Y-Intercept (HK)’s AstraZeneca AZN Stock Holding History

Y-Intercept (HK)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-33,322	Closed	-$5.11M	–	1534
2025 Q3	$5.11M	Buy	33,322 +17,574	+112%	+$2.66M	0.12%	201
2025 Q2	$2.2M	Sell	15,748 -680	-4%	-$95.3K	0.05%	558
2025 Q1	$2.41M	Buy	+16,428	New	+$2.38M	0.16%	151
2024 Q4	–	Sell	-19,344	Closed	-$3.01M	–	1181
2024 Q3	$3.01M	Buy	19,344 +9,256	+92%	+$1.49M	0.18%	120
2024 Q2	$1.57M	Buy	+10,088	New	+$1.52M	0.09%	320
2024 Q1	–	Sell	-7,790	Closed	-$1.05M	–	1365
2023 Q4	$1.05M	Buy	+7,790	New	+$1.01M	0.1%	303
2023 Q3	–	Sell	-18,634	Closed	-$2.67M	–	1065
2023 Q2	$2.67M	Buy	+18,634	New	+$2.74M	0.28%	68
2023 Q1	–	Sell	-5,561	Closed	-$754K	–	1171
2022 Q4	$754K	Buy	+5,561	New	+$697K	0.11%	286
2021 Q2	–	Sell	-9,570	Closed	-$956K	–	623
2021 Q1	$956K	Buy	+9,570	New	+$962K	0.26%	104

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Y-Intercept (HK)'s AZN Position: Q4 2025 in Review

Y-Intercept (HK) sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 33,322 shares — an estimated $5.11M sold.

Y-Intercept (HK) first reported a position in AZN in Q1 2021 and held it in 9 quarters. The position peaked at $5.11M in Q3 2025. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Y-Intercept (HK) reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
Y-Intercept (HK) sold 33,322 AstraZeneca shares in Q4 2025, an estimated $5.11M.
Y-Intercept (HK) first reported a position in AstraZeneca in Q1 2021 and held it in 9 quarters.
Y-Intercept (HK)'s AstraZeneca position peaked at $5.11M in Q3 2025.
1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.